Venancio de Lima Eduardo Oliveira, Tasima Lídia Jorge, Hatakeyama Daniela Miki, Farias Rodrigues Maria Amélia, Serino-Silva Caroline, Stuginski Daniel Rodrigues, Machado da Silveira Giovanni Perez, Prezoto Benedito Carlos, Grego Kathleen Fernandes, Sant'Anna Sávio Stefanini, Tanaka-Azevedo Anita Mitico, de Morais-Zani Karen
Laboratório de Herpetologia, Instituto Butantan, São Paulo, Brazil; Programa de Pós-Graduação Interunidades em Biotecnologia, São Paulo, Brazil.
Laboratório de Fisiopatologia, Instituto Butantan, São Paulo, Brazil.
Toxicon. 2025 Feb;255:108231. doi: 10.1016/j.toxicon.2025.108231. Epub 2025 Jan 7.
Coagulation disorders are a primary symptom of envenomation caused by snakes belonging to the genus Bothrops. In the Northeast region of Brazil, the species Bothrops erythromelas and Bothrops leucurus are the main responsible for snakebite accidents. Due to the specific action of Bothrops venoms on several components of the coagulation cascade, the objective of this work was to characterize the coagulotoxic profile of B. erythromelas and B. leucurus venoms and the neutralizing potential of bothropic antivenom, considering that their venom are not used in the production of antivenom. Regarding the clotting components targeted by the venom of these species, B. leucurus samples had higher thrombin-like activity and ability to activate prothrombin, while the activation of Factor X was comparable between these two species. B.erythromelas and B. leucurus venom displayed α- and β-fibrinogenolytic activities, with the former presenting higher overall fibrinogenolytic activity. In contrast, B. erythromelas venom showed greater procoagulant activity on human plasma, assessed through the coagulation time induced by the venom samples and thromboelastometry. Bothropic antivenom inhibited the procoagulant potential of B. leucurus venom better than B. erythromelas. However, the ability of the antivenom to neutralize this activity is lower compared to that determined for the venom of B. jararaca, which is used for antivenom production. The results shown herein describe the procoagulant activity of B. leucurus and B. erythromelas venoms and highlight the differences regarding their procoagulant capacity on human plasma, contributing to a deeper understanding of the pathophysiology of the envenomation caused by these species.
凝血功能障碍是由具窍蝮蛇属蛇类咬伤所致中毒的主要症状。在巴西东北部地区,红具窍蝮蛇和白具窍蝮蛇是导致蛇咬伤事故的主要蛇种。由于具窍蝮蛇毒液对凝血级联反应的多个成分具有特定作用,鉴于它们的毒液未用于抗蛇毒血清的生产,本研究的目的是表征红具窍蝮蛇和白具窍蝮蛇毒液的凝血毒性特征以及双价抗蛇毒血清的中和潜力。关于这些蛇种毒液所靶向的凝血成分,白具窍蝮蛇样本具有更高的类凝血酶活性和激活凝血酶原的能力,而这两个蛇种之间因子X的激活情况相当。红具窍蝮蛇和白具窍蝮蛇毒液均表现出α和β纤维蛋白溶解活性,前者的总体纤维蛋白溶解活性更高。相比之下,通过毒液样本诱导的凝血时间和血栓弹力图评估,红具窍蝮蛇毒液对人血浆显示出更大的促凝血活性。双价抗蛇毒血清对白具窍蝮蛇毒液促凝血潜力的抑制作用优于红具窍蝮蛇毒液。然而,与用于生产抗蛇毒血清的巴西矛头蝮蛇毒液相比,该抗蛇毒血清中和这种活性的能力较低。本文所示结果描述了白具窍蝮蛇和红具窍蝮蛇毒液的促凝血活性,并突出了它们对人血浆促凝血能力的差异,有助于更深入地了解这些蛇种所致中毒的病理生理学。